Trastuzumab and fulvestrant combination therapy for women with advanced breast cancer positive for hormone receptor and human epidermal growth factor receptor 2 : a retrospective single-center study
Available in National Diet Library
Find on the publisher's website
NDL Digital Collections
Digital data available
Check on the publisher's website
DOI[10.1186/s12885-021-09128-1]to the data of the same series
Search by Bookstore
Read this material in an accessible format.
Search by Bookstore
Read in Disability Resources
- Other Services
Bibliographic Record
You can check the details of this material, its authority (keywords that refer to materials on the same subject, author's name, etc.), etc.
- Material Type
- 博士論文
- Author/Editor
- 尾崎, 由記範
- Publication, Distribution, etc.
- Publication Date
- 2022
- Publication Date (W3CDTF)
- 2022
- Alternative Title
- HR陽性HER2陽性転移再発乳癌に対するトラスツズマブ+フルベストラント併用療法の効果 : 後方視的研究
- Degree grantor/type
- 東京医科歯科大学
- Date Granted
- 2022-03-17
- Date Granted (W3CDTF)
- 2022-03-17